Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

The utility of total lipid core burden index/maximal lipid core burden index ratio within the culprit plaque to predict filter-no reflow: insight from near-infrared spectroscopy with intravascular ultrasound.

Sato T, Aizawa Y, Suzuki N, Taya Y, Yuasa S, Kishi S, Koshikawa T, Fuse K, Fujita S, Ikeda Y, Kitazawa H, Takahashi M, Okabe M.

J Thromb Thrombolysis. 2018 Jun 18. doi: 10.1007/s11239-018-1697-z. [Epub ahead of print]

PMID:
29915959
2.

Migration of lymphatic endothelial cells and lymphatic vascular development in the craniofacial region of embryonic mice.

Taya Y, Sato K, Shirako Y, Soeno Y.

Int J Dev Biol. 2018;62(4-5):293-301. doi: 10.1387/ijdb.170218yt.

PMID:
29877568
3.

Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.

Kimura M, Araoka H, Yamamoto H, Nakamura S, Nagi M, Yamagoe S, Miyazaki Y, Ogura S, Mitsuki T, Yuasa M, Kaji D, Kageyama K, Nishida A, Taya Y, Shimazu H, Ishiwata K, Takagi S, Yamamoto G, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02183-17. doi: 10.1128/AAC.02183-17. Print 2018 May.

PMID:
29530846
4.

Surgically Diagnosed Primary Hepatic Angiosarcoma.

Tsunematsu S, Muto S, Oi H, Naka T, Kitagataya T, Sasaki R, Taya Y, Baba U, Tsukamoto Y, Uemura K, Kimura T, Ohara Y.

Intern Med. 2018 Mar 1;57(5):687-691. doi: 10.2169/internalmedicine.9318-17. Epub 2017 Nov 20.

5.

Successful Treatment of Pulmonary Mucormycosis Caused by Cunninghamella bertholletiae with High-Dose Liposomal Amphotericin B (10 mg/kg/day) Followed by a Lobectomy in Cord Blood Transplant Recipients.

Ota H, Yamamoto H, Kimura M, Araoka H, Fujii T, Umeyama T, Ohno H, Miyazaki Y, Kaji D, Taya Y, Nishida A, Ishiwata K, Tsuji M, Takagi S, Asano-Mori Y, Yamamoto G, Uchida N, Izutsu K, Masuoka K, Wake A, Yoneyama A, Makino S, Taniguchi S.

Mycopathologia. 2017 Oct;182(9-10):847-853. doi: 10.1007/s11046-017-0149-1. Epub 2017 Jun 2.

PMID:
28577122
6.

Depleting dietary valine permits nonmyeloablative mouse hematopoietic stem cell transplantation.

Taya Y, Ota Y, Wilkinson AC, Kanazawa A, Watarai H, Kasai M, Nakauchi H, Yamazaki S.

Science. 2016 Dec 2;354(6316):1152-1155. Epub 2016 Oct 20.

PMID:
27934766
7.

Erratum to: Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort study.

Kubo K, Kawakami H, Kuwatani M, Nishida M, Kawakubo K, Kawahata S, Taya Y, Kubota Y, Amano T, Shirato H, Sakamoto N.

BMC Gastroenterol. 2016 Sep 20;16(1):116. No abstract available.

8.

Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study.

Kubo K, Kawakami H, Kuwatani M, Nishida M, Kawakubo K, Kawahata S, Taya Y, Kubota Y, Amano T, Shirato H, Sakamoto N.

BMC Gastroenterol. 2016 Jul 8;16(1):65. doi: 10.1186/s12876-016-0479-3. Erratum in: BMC Gastroenterol. 2016;16:116.

9.

Lower incidence of complications in endoscopic nasobiliary drainage for hilar cholangiocarcinoma.

Kawakubo K, Kawakami H, Kuwatani M, Haba S, Kudo T, Taya YA, Kawahata S, Kubota Y, Kubo K, Eto K, Ehira N, Yamato H, Onodera M, Sakamoto N.

World J Gastrointest Endosc. 2016 May 10;8(9):385-90. doi: 10.4253/wjge.v8.i9.385.

10.

Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells.

Ezawa I, Sawai Y, Kawase T, Okabe A, Tsutsumi S, Ichikawa H, Kobayashi Y, Tashiro F, Namiki H, Kondo T, Semba K, Aburatani H, Taya Y, Nakagama H, Ohki R.

Cancer Sci. 2016 Jun;107(6):734-45. doi: 10.1111/cas.12933. Epub 2016 May 16.

11.

IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis.

Asano Y, Kawase T, Okabe A, Tsutsumi S, Ichikawa H, Tatebe S, Kitabayashi I, Tashiro F, Namiki H, Kondo T, Semba K, Aburatani H, Taya Y, Nakagama H, Ohki R.

Sci Rep. 2016 Jan 12;6:19174. doi: 10.1038/srep19174.

12.

MALT1 Inhibition of Oral Carcinoma Cell Invasion and ERK/MAPK Activation.

Chiba T, Soeno Y, Shirako Y, Sudo H, Yagishita H, Taya Y, Kawashiri S, Okada Y, Imai K.

J Dent Res. 2016 Apr;95(4):446-52. doi: 10.1177/0022034515621740. Epub 2015 Dec 23.

PMID:
26701346
13.

Retraction notice to "Regulation of p53: Intricate loops and delicate balances" [Biochem. Pharmacol. 64 (2002) 865-871].

Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, Martinez Leal JF, Maya R, Moas M, Seger R, Taya Y, Ben-Ze'ev A.

Biochem Pharmacol. 2015 Aug 15;96(4):369. doi: 10.1016/j.bcp.2015.07.001. No abstract available.

PMID:
26465018
14.

Embryonic tongue morphogenesis in an organ culture model of mouse mandibular arches: blocking Sonic hedgehog signaling leads to microglossia.

Torii D, Soeno Y, Fujita K, Sato K, Aoba T, Taya Y.

In Vitro Cell Dev Biol Anim. 2016 Jan;52(1):89-99. doi: 10.1007/s11626-015-9951-6. Epub 2015 Sep 3.

PMID:
26334330
15.

Three-Dimensional Visualization of Developing Neurovascular Architecture in the Craniofacial Region of Embryonic Mice.

Sugimoto T, Taya Y, Shimazu Y, Soeno Y, Sato K, Aoba T.

Anat Rec (Hoboken). 2015 Nov;298(11):1824-35. doi: 10.1002/ar.23179. Epub 2015 Aug 3.

16.

Heterogeneous tumor stromal microenvironments of oral squamous cell carcinoma cells in tongue and nodal metastatic lesions in a xenograft mouse model.

Shirako Y, Taya Y, Sato K, Chiba T, Imai K, Shimazu Y, Aoba T, Soeno Y.

J Oral Pathol Med. 2015 Oct;44(9):656-68. doi: 10.1111/jop.12318. Epub 2015 Mar 13.

PMID:
25765182
17.

TSPAN12 is a critical factor for cancer-fibroblast cell contact-mediated cancer invasion.

Otomo R, Otsubo C, Matsushima-Hibiya Y, Miyazaki M, Tashiro F, Ichikawa H, Kohno T, Ochiya T, Yokota J, Nakagama H, Taya Y, Enari M.

Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18691-6. doi: 10.1073/pnas.1412062112. Epub 2014 Dec 15.

18.

PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors.

Ohki R, Saito K, Chen Y, Kawase T, Hiraoka N, Saigawa R, Minegishi M, Aita Y, Yanai G, Shimizu H, Yachida S, Sakata N, Doi R, Kosuge T, Shimada K, Tycko B, Tsukada T, Kanai Y, Sumi S, Namiki H, Taya Y, Shibata T, Nakagama H.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):E2404-13. doi: 10.1073/pnas.1319962111. Epub 2014 May 27.

19.

Distinct and site-specific phosphorylation of the retinoblastoma protein at serine 612 in differentiated cells.

Hattori T, Uchida C, Takahashi H, Yamamoto N, Naito M, Taya Y.

PLoS One. 2014 Jan 21;9(1):e86709. doi: 10.1371/journal.pone.0086709. eCollection 2014.

20.

Interaction between RB protein and NuMA is required for proper alignment of spindle microtubules.

Uchida C, Hattori T, Takahashi H, Yamamoto N, Kitagawa M, Taya Y.

Genes Cells. 2014 Feb;19(2):89-96. doi: 10.1111/gtc.12119. Epub 2013 Dec 19.

21.

Cytoplasmic translocation of the retinoblastoma protein disrupts sarcomeric organization.

Araki K, Kawauchi K, Hirata H, Yamamoto M, Taya Y.

Elife. 2013 Dec 3;2:e01228. doi: 10.7554/eLife.01228.

22.

Three-dimensional reconstruction of oral tongue squamous cell carcinoma at invasion front.

Kudo T, Shimazu Y, Yagishita H, Izumo T, Soeno Y, Sato K, Taya Y, Aoba T.

Int J Dent. 2013;2013:482765. doi: 10.1155/2013/482765. Epub 2013 Oct 21.

23.

Molecular contribution to cleft palate production in cleft lip mice.

Sasaki Y, Taya Y, Saito K, Fujita K, Aoba T, Fujiwara T.

Congenit Anom (Kyoto). 2014 May;54(2):94-9. doi: 10.1111/cga.12038.

24.

Generation of a mouse model with down-regulated U50 snoRNA (SNORD50) expression and its organ-specific phenotypic modulation.

Soeno Y, Fujita K, Kudo T, Asagiri M, Kakuta S, Taya Y, Shimazu Y, Sato K, Tanaka-Fujita R, Kubo S, Iwakura Y, Nakamura Y, Mori S, Aoba T.

PLoS One. 2013 Aug 26;8(8):e72105. doi: 10.1371/journal.pone.0072105. eCollection 2013.

25.

Pneumothorax in an early phase after allogeneic hematopoietic stem cell transplantation.

Ebihara Y, Yamamoto S, Mochizuki S, Tsukada M, Taya Y, Kawakita T, Kato S, Ooi J, Takahashi S, Tojo A, Tsuji K.

Hematol Rep. 2013 Jun 28;5(2):34-5. doi: 10.4081/hr.2013.e10. Print 2013 Jun 28.

26.

NuMA is required for the selective induction of p53 target genes.

Ohata H, Miyazaki M, Otomo R, Matsushima-Hibiya Y, Otsubo C, Nagase T, Arakawa H, Yokota J, Nakagama H, Taya Y, Enari M.

Mol Cell Biol. 2013 Jun;33(12):2447-57. doi: 10.1128/MCB.01221-12. Epub 2013 Apr 15.

27.

Molecular signaling at the fusion stage of the mouse mandibular arch: involvement of insulin-like growth factor family.

Fujita K, Taya Y, Shimazu Y, Aoba T, Soeno Y.

Int J Dev Biol. 2013;57(5):399-406. doi: 10.1387/ijdb.120110ys.

28.

MOZ increases p53 acetylation and premature senescence through its complex formation with PML.

Rokudai S, Laptenko O, Arnal SM, Taya Y, Kitabayashi I, Prives C.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3895-900. doi: 10.1073/pnas.1300490110. Epub 2013 Feb 19.

29.

Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch.

Hashimoto T, Soeno Y, Maeda G, Taya Y, Aoba T, Nasu M, Kawashiri S, Imai K.

PLoS One. 2012;7(10):e47899. doi: 10.1371/journal.pone.0047899. Epub 2012 Oct 23.

30.

Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer.

Arima Y, Hayashi H, Sasaki M, Hosonaga M, Goto TM, Chiyoda T, Kuninaka S, Shibata T, Ohata H, Nakagama H, Taya Y, Saya H.

J Biol Chem. 2012 Mar 9;287(11):7896-906. doi: 10.1074/jbc.M111.313759. Epub 2012 Jan 19.

31.

Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.

Benosman S, Meng X, Von Grabowiecki Y, Palamiuc L, Hritcu L, Gross I, Mellitzer G, Taya Y, Loeffler JP, Gaiddon C.

J Biol Chem. 2011 Dec 16;286(50):43013-25. doi: 10.1074/jbc.M111.261271. Epub 2011 Oct 14.

32.

Cancer susceptibility polymorphism of p53 at codon 72 affects phosphorylation and degradation of p53 protein.

Ozeki C, Sawai Y, Shibata T, Kohno T, Okamoto K, Yokota J, Tashiro F, Tanuma S, Sakai R, Kawase T, Kitabayashi I, Taya Y, Ohki R.

J Biol Chem. 2011 May 20;286(20):18251-60. doi: 10.1074/jbc.M110.208587. Epub 2011 Mar 28.

33.

Identification of novel ribonucleo-protein complexes from the brain-specific snoRNA MBII-52.

Soeno Y, Taya Y, Stasyk T, Huber LA, Aoba T, Hüttenhofer A.

RNA. 2010 Jul;16(7):1293-300. doi: 10.1261/rna.2109710. Epub 2010 May 19.

34.

Requirement of ATM for rapid p53 phosphorylation at Ser46 without Ser/Thr-Gln sequences.

Kodama M, Otsubo C, Hirota T, Yokota J, Enari M, Taya Y.

Mol Cell Biol. 2010 Apr;30(7):1620-33. doi: 10.1128/MCB.00810-09. Epub 2010 Feb 1.

35.

Optical and paramagnetic properties of size-controlled ink particles isolated from Sepia officinalis.

Matsuura T, Hino M, Akutagawa S, Shimoyama Y, Kobayashi T, Taya Y, Ueno T.

Biosci Biotechnol Biochem. 2009 Dec;73(12):2790-2. Epub 2009 Dec 7.

36.

Identification of a function-specific mutation of clathrin heavy chain (CHC) required for p53 transactivation.

Ohata H, Ota N, Shirouzu M, Yokoyama S, Yokota J, Taya Y, Enari M.

J Mol Biol. 2009 Dec 4;394(3):460-71. doi: 10.1016/j.jmb.2009.09.029. Epub 2009 Sep 18.

PMID:
19766654
37.

A photochemical detection of methylcytosine by using hydrophobic interaction.

Ami T, Ogino M, Taya Y, Takemura Y, Fujimoto K.

Nucleic Acids Symp Ser (Oxf). 2009;(53):203-4. doi: 10.1093/nass/nrp102.

PMID:
19749331
38.

Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.

Okamoto K, Taya Y, Nakagama H.

FEBS Lett. 2009 Sep 3;583(17):2710-4. doi: 10.1016/j.febslet.2009.07.021. Epub 2009 Jul 18.

39.

Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2.

Ohtsubo C, Shiokawa D, Kodama M, Gaiddon C, Nakagama H, Jochemsen AG, Taya Y, Okamoto K.

Cancer Sci. 2009 Jul;100(7):1291-9. doi: 10.1111/j.1349-7006.2009.01180.x. Epub 2009 Apr 27.

40.

Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry.

Kubo H, Shimizu M, Taya Y, Kawamoto T, Michida M, Kaneko E, Igarashi A, Nishimura M, Segoshi K, Shimazu Y, Tsuji K, Aoba T, Kato Y.

Genes Cells. 2009 Mar;14(3):407-24. doi: 10.1111/j.1365-2443.2009.01281.x. Epub 2009 Feb 17.

41.

PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt.

Kawase T, Ohki R, Shibata T, Tsutsumi S, Kamimura N, Inazawa J, Ohta T, Ichikawa H, Aburatani H, Tashiro F, Taya Y.

Cell. 2009 Feb 6;136(3):535-50. doi: 10.1016/j.cell.2008.12.002.

42.

Highly selective detection of 5-methylcytosine using photochemical ligation.

Ogino M, Taya Y, Fujimoto K.

Chem Commun (Camb). 2008 Dec 7;(45):5996-8. doi: 10.1039/b813677g. Epub 2008 Oct 14.

PMID:
19030564
43.

Monocytic leukemia zinc finger (MOZ) interacts with p53 to induce p21 expression and cell-cycle arrest.

Rokudai S, Aikawa Y, Tagata Y, Tsuchida N, Taya Y, Kitabayashi I.

J Biol Chem. 2009 Jan 2;284(1):237-44. doi: 10.1074/jbc.M805101200. Epub 2008 Nov 10.

44.

Effective synthesis of photosensitive oligodeoxynucleotides.

Ogino M, Taya Y, Fujimoto K.

Nucleic Acids Symp Ser (Oxf). 2008;(52):395-6. doi: 10.1093/nass/nrn201.

PMID:
18776420
45.

Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.

Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y.

Cancer Res. 2008 Jul 1;68(13):5104-12. doi: 10.1158/0008-5472.CAN-07-5680.

46.

Regulation of clathrin-mediated endocytosis by p53.

Endo Y, Sugiyama A, Li SA, Ohmori K, Ohata H, Yoshida Y, Shibuya M, Takei K, Enari M, Taya Y.

Genes Cells. 2008 Apr;13(4):375-86. doi: 10.1111/j.1365-2443.2008.01172.x.

47.

Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2.

Abe Y, Oda-Sato E, Tobiume K, Kawauchi K, Taya Y, Okamoto K, Oren M, Tanaka N.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4838-43. doi: 10.1073/pnas.0712216105. Epub 2008 Mar 21.

48.

p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis.

Kawase T, Ichikawa H, Ohta T, Nozaki N, Tashiro F, Ohki R, Taya Y.

Oncogene. 2008 Jun 19;27(27):3797-810. doi: 10.1038/onc.2008.32. Epub 2008 Feb 11.

PMID:
18264133
49.

Monomeric but not trimeric clathrin heavy chain regulates p53-mediated transcription.

Ohmori K, Endo Y, Yoshida Y, Ohata H, Taya Y, Enari M.

Oncogene. 2008 Apr 3;27(15):2215-27. Epub 2007 Oct 22.

PMID:
17952123
50.

CIP2A inhibits PP2A in human malignancies.

Junttila MR, Puustinen P, Niemelä M, Ahola R, Arnold H, Böttzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grènman R, Kast J, Kallunki T, Sears R, Kähäri VM, Westermarck J.

Cell. 2007 Jul 13;130(1):51-62.

Supplemental Content

Support Center